Investigating Meningococcal Vaccines in Adults - An Exploratory, Open-label, Immunogenicity Study of a Licensed Meningococcal Capsular Group B Vaccine (4CMenB, Bexsero) in Adults
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2017
At a glance
- Drugs Meningococcal vaccine group B (Primary)
- Indications Meningococcal group B infections
- Focus Pharmacodynamics
- 28 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
- 13 Oct 2016 Planned End Date changed from 1 Aug 2016 to 1 Dec 2016.
- 13 Oct 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016.